69.95
price down icon2.36%   -1.69
after-market Handel nachbörslich: 69.20 -0.75 -1.07%
loading
Schlusskurs vom Vortag:
$71.64
Offen:
$71.28
24-Stunden-Volumen:
475.47K
Relative Volume:
0.87
Marktkapitalisierung:
$5.01B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-224.29M
KGV:
-17.94
EPS:
-3.9
Netto-Cashflow:
$-185.06M
1W Leistung:
-0.07%
1M Leistung:
-10.27%
6M Leistung:
-30.86%
1J Leistung:
+11.46%
1-Tages-Spanne:
Value
$69.78
$73.06
1-Wochen-Bereich:
Value
$67.62
$73.06
52-Wochen-Spanne:
Value
$55.53
$113.51

Nuvalent Inc Stock (NUVL) Company Profile

Name
Firmenname
Nuvalent Inc
Name
Telefon
508-446-2272
Name
Adresse
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Name
Mitarbeiter
142
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
NUVL's Discussions on Twitter

Vergleichen Sie NUVL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NUVL
Nuvalent Inc
69.95 5.01B 0 -224.29M -185.06M -3.90
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Nuvalent Inc Stock (NUVL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-14 Hochstufung UBS Neutral → Buy
2024-12-30 Eingeleitet H.C. Wainwright Buy
2024-10-24 Eingeleitet UBS Neutral
2024-08-29 Eingeleitet Barclays Overweight
2024-04-17 Eingeleitet Jefferies Buy
2024-04-01 Hochstufung Leerink Partners Market Perform → Outperform
2024-02-28 Fortgesetzt Guggenheim Buy
2024-02-23 Eingeleitet Robert W. Baird Outperform
2023-09-27 Eingeleitet Stifel Buy
2023-08-08 Eingeleitet SVB Securities Market Perform
2023-07-24 Eingeleitet Guggenheim Buy
2023-01-18 Eingeleitet Wedbush Outperform
2022-06-24 Eingeleitet BMO Capital Markets Outperform
Alle ansehen

Nuvalent Inc Aktie (NUVL) Neueste Nachrichten

pulisher
06:09 AM

UBS gives a Buy recommendation for Nuvalent Inc (NUVL) - knoxdaily.com

06:09 AM
pulisher
Apr 18, 2025

JPMorgan Chase & Co. Acquires 47,818 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 18, 2025
pulisher
Apr 18, 2025

Trend Tracker for (NUVL) - news.stocktradersdaily.com

Apr 18, 2025
pulisher
Apr 17, 2025

Nuvalent Board Member Resigns, Joins Advisory Board - TipRanks

Apr 17, 2025
pulisher
Apr 16, 2025

Alliancebernstein L.P. Purchases 500 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 16, 2025
pulisher
Apr 11, 2025

Commonwealth Equity Services LLC Raises Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Sei Investments Co. Reduces Stock Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 10, 2025
pulisher
Apr 08, 2025

Nuvalent: Cannot Make Sense Of The Valuation - Seeking Alpha

Apr 08, 2025
pulisher
Apr 07, 2025

Nuvalent stock touches 52-week low at $61.75 amid market shifts By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Nuvalent stock touches 52-week low at $61.75 amid market shifts - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

Norges Bank Invests $24.95 Million in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 07, 2025
pulisher
Apr 03, 2025

KLP Kapitalforvaltning AS Buys New Shares in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

What to Expect at AACR 2025: Nuvalent to present Data on Neladalkib and Zidesamtinib - Onco'Zine

Apr 02, 2025
pulisher
Apr 02, 2025

Commit To Purchase Nuvalent At $55, Earn 11.9% Annualized Using Options - Nasdaq

Apr 02, 2025
pulisher
Apr 01, 2025

(NUVL) On The My Stocks Page - news.stocktradersdaily.com

Apr 01, 2025
pulisher
Apr 01, 2025

Is Nuvalent (NUVL) the Best Debt Free Mid Cap Stock to Buy Now? - Yahoo

Apr 01, 2025
pulisher
Apr 01, 2025

Nuvalent to Participate in the Stifel 2025 Virtual Targeted Oncology Forum - Quantisnow

Apr 01, 2025
pulisher
Apr 01, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Apr 01, 2025
pulisher
Mar 30, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Stake Cut by Virtu Financial LLC - MarketBeat

Mar 30, 2025
pulisher
Mar 30, 2025

Teacher Retirement System of Texas Boosts Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

Why Nuvalent (NUVL) Is Among the Best Mid Cap Biotech Stocks to Buy - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

Nuvalent chief development officer sells shares worth $292,468 By Investing.com - Investing.com Philippines

Mar 29, 2025
pulisher
Mar 29, 2025

10 Best Debt Free Mid Cap Stocks to Buy Now - Insider Monkey

Mar 29, 2025
pulisher
Mar 28, 2025

Nuvalent chief development officer sells shares worth $292,468 - Investing.com India

Mar 28, 2025
pulisher
Mar 26, 2025

10 Best Mid Cap Biotech Stocks to Buy - Insider Monkey

Mar 26, 2025
pulisher
Mar 25, 2025

Nuvalent to Present New Preclinical Data on ALK-Selective Inhibitor, Neladalkib, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2025 - Nasdaq

Mar 25, 2025
pulisher
Mar 25, 2025

Breakthrough Cancer Drug Data: New Brain-Penetrant Therapy Shows Promise Against Resistant Tumors - Stock Titan

Mar 25, 2025
pulisher
Mar 24, 2025

Connor Clark & Lunn Investment Management Ltd. Sells 18,609 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat

Mar 24, 2025
pulisher
Mar 22, 2025

How the (NUVL) price action is used to our Advantage - news.stocktradersdaily.com

Mar 22, 2025
pulisher
Mar 21, 2025

Raymond James Financial Inc. Acquires Shares of 133,964 Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

Nuvalent CEO Porter sells $2.05 million in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Nuvalent CEO Porter sells $2.05 million in stock - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Victory Capital Management Inc. Cuts Stock Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 19, 2025
pulisher
Mar 19, 2025

Charles Schwab Investment Management Inc. Buys 7,742 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

US Bancorp DE Invests $90,000 in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 18, 2025
pulisher
Mar 15, 2025

Bank of New York Mellon Corp Increases Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

UBS Upgrades Nuvalent (NUVL) - Nasdaq

Mar 14, 2025
pulisher
Mar 14, 2025

Nuvalent upgraded to Buy from Neutral at UBS - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

UBS Upgrades Nuvalent to Buy From Neutral, Maintains $100 Price Target -March 14, 2025 at 07:24 am EDT - Marketscreener.com

Mar 14, 2025
pulisher
Mar 08, 2025

Principal Financial Group Inc. Cuts Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

HC Wainwright Has Negative Forecast for Nuvalent Q1 Earnings - Defense World

Mar 06, 2025
pulisher
Mar 04, 2025

Nuvalent’s (NUVL) Buy Rating Reaffirmed at HC Wainwright - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

H.C. Wainwright maintains Buy on Nuvalent stock, $110 target By Investing.com - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

New York State Common Retirement Fund Sells 2,495 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Where are the Opportunities in (NUVL) - news.stocktradersdaily.com

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Has $3.95 Million Stake in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Nuvalent’s Strategic Advances in NSCLC Trials Justify Buy Rating - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Nuvalent to Participate in Upcoming March Investor Conferences - Citizentribune

Feb 28, 2025
pulisher
Feb 28, 2025

Nuvalent, Inc. Reports 2024 Financial Results and Pipeline Progress - TipRanks

Feb 28, 2025
pulisher
Feb 27, 2025

Nuvalent Outlines Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2024 Financial Results - The Malaysian Reserve

Feb 27, 2025

Finanzdaten der Nuvalent Inc-Aktie (NUVL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
Kapitalisierung:     |  Volumen (24h):